Boris Kantor

Adjunct Professor in the Department of Neurobiology

boris.kantor@duke.edu

ORCID iD

https://orcid.org/0000-0002-8347-7992

Box 3209, Durham, NC 27710

Bryan Research Building, 311 Research Drive Room 213, Durham, NC 27710

More About This Person

At a Glance

Credentials
1. Education

Academic Experience

Global Scholarship

Keywords

Research
1. Selected Grants
2. External Relationships

Scholarly Works

Teaching & Mentoring

Recognition

Professional Activities
1. Service to Duke

Embed Profile Data

Embed Profile Data

Scholarly Works - Conferences

CRISPR/Cas9 Inducible Systems for Neurodegenerative Disease

Conference MOLECULAR THERAPY · April 27, 2021 Link to item Cite

Policies and Pitfalls: What the Alzheimer's Community Can Learn from the Deployment of Disease-Modifying Therapies for Multiple Sclerosis Patients

Conference MOLECULAR THERAPY · April 27, 2021 Link to item Cite

Downregulation of SNCA Expression as a Therapoetic Approach for Parkinson's Disease and Other Synucleinopathies: New Target Validation for Next-Generation Drug Discovery

Conference MOLECULAR THERAPY · April 27, 2021 Link to item Cite

The New Frontier in the Development of LOAD Therapies Targeting APOE

Conference MOLECULAR THERAPY · April 27, 2021 Link to item Cite

Epigenome-Base Strategies for Efficient and Safe Editing of APOEε4 Allele: Implications for Alzheimer's Disease

Conference MOLECULAR THERAPY · April 27, 2021 Link to item Cite

Implications of Gene Therapy for Alzheimer's

Conference MOLECULAR THERAPY · April 28, 2020 Link to item Cite

Epigenetic Downregulation of ApoE4 for Alzheimer's Disease

Conference MOLECULAR THERAPY · April 28, 2020 Link to item Cite

Allele Specific Knockdown of APOE e4 Expression: A Novel Platform for Precision Gene Therapy in Alzheimer's Disease

Conference MOLECULAR THERAPY · April 28, 2020 Link to item Cite

Development of Lentiviral Platform for Allele-Specific Targeted Down-Regulation of APOEe4 Expression: Epigenetic Therapy for Precision Medicine in Alzheimer's Disease

Conference MOLECULAR THERAPY · April 28, 2020 Link to item Cite

An Isogenic hiPSC-Derived Model System for Establishing Gene Therapy Approaches in Alzheimer's Disease

Conference MOLECULAR THERAPY · April 28, 2020 Link to item Cite

Integrase-Deficient Lentiviral Vector for Efficient CRISPR/Cas9-Mediated Gene and Epigenome-Editing Applications

Conference MOLECULAR THERAPY · April 22, 2019 Link to item Cite

The New Epigenome-Editing Approach for Targeting Dysregulated SNCA Expression: Novel Target Validation for Next-Generation Drug Discovery

Conference MOLECULAR THERAPY · April 22, 2019 Link to item Cite

The Prader-Willi/Angelman imprinted domain and its control center.

Conference Cytogenet Genome Res · 2006 The present review focuses on the recent advances towards understanding the mode of operation of the imprinting center (IC) within the Prader-Willi/Angelman syndromes (PWS/AS) domain. Special emphasis is put on the elucidation of the functional interaction ... Full text Link to item Cite

By what mechanism does glucose-insulin-potassium improve survival following myocardial infarction?

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 1, 2001 Link to item Cite